nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—CYP2A6—Fluorouracil—skin cancer	0.167	0.264	CbGbCtD
Letrozole—CYP3A4—Imiquimod—skin cancer	0.136	0.215	CbGbCtD
Letrozole—CYP3A4—Temozolomide—skin cancer	0.136	0.215	CbGbCtD
Letrozole—CYP3A4—Vismodegib—skin cancer	0.0941	0.149	CbGbCtD
Letrozole—CYP3A4—Vemurafenib—skin cancer	0.0744	0.118	CbGbCtD
Letrozole—CYP3A4—Docetaxel—skin cancer	0.0255	0.0403	CbGbCtD
Letrozole—Pain—Imiquimod—skin cancer	0.000539	0.00147	CcSEcCtD
Letrozole—Acute coronary syndrome—Fluorouracil—skin cancer	0.000538	0.00146	CcSEcCtD
Letrozole—Myocardial infarction—Fluorouracil—skin cancer	0.000535	0.00146	CcSEcCtD
Letrozole—Haemoglobin—Temozolomide—skin cancer	0.000535	0.00145	CcSEcCtD
Letrozole—Stomatitis—Fluorouracil—skin cancer	0.000532	0.00145	CcSEcCtD
Letrozole—Haemorrhage—Temozolomide—skin cancer	0.000532	0.00145	CcSEcCtD
Letrozole—Hepatitis—Temozolomide—skin cancer	0.000532	0.00145	CcSEcCtD
Letrozole—Urinary tract infection—Fluorouracil—skin cancer	0.000531	0.00144	CcSEcCtD
Letrozole—Asthenia—Vemurafenib—skin cancer	0.00053	0.00144	CcSEcCtD
Letrozole—Hypoaesthesia—Temozolomide—skin cancer	0.000529	0.00144	CcSEcCtD
Letrozole—Urinary tract disorder—Temozolomide—skin cancer	0.000525	0.00143	CcSEcCtD
Letrozole—Oedema peripheral—Temozolomide—skin cancer	0.000524	0.00143	CcSEcCtD
Letrozole—Cardiac failure—Docetaxel—skin cancer	0.000524	0.00143	CcSEcCtD
Letrozole—Pruritus—Vemurafenib—skin cancer	0.000523	0.00142	CcSEcCtD
Letrozole—Connective tissue disorder—Temozolomide—skin cancer	0.000523	0.00142	CcSEcCtD
Letrozole—Lethargy—Docetaxel—skin cancer	0.000522	0.00142	CcSEcCtD
Letrozole—Urethral disorder—Temozolomide—skin cancer	0.000521	0.00142	CcSEcCtD
Letrozole—Alopecia—Dactinomycin—skin cancer	0.00052	0.00141	CcSEcCtD
Letrozole—Feeling abnormal—Imiquimod—skin cancer	0.00052	0.00141	CcSEcCtD
Letrozole—Gastrointestinal pain—Imiquimod—skin cancer	0.000516	0.0014	CcSEcCtD
Letrozole—Pain in extremity—Docetaxel—skin cancer	0.000511	0.00139	CcSEcCtD
Letrozole—Ill-defined disorder—Bleomycin—skin cancer	0.000509	0.00139	CcSEcCtD
Letrozole—Diarrhoea—Vemurafenib—skin cancer	0.000506	0.00138	CcSEcCtD
Letrozole—Erythema multiforme—Temozolomide—skin cancer	0.000503	0.00137	CcSEcCtD
Letrozole—Urticaria—Imiquimod—skin cancer	0.000501	0.00136	CcSEcCtD
Letrozole—Abdominal pain—Imiquimod—skin cancer	0.000498	0.00136	CcSEcCtD
Letrozole—Body temperature increased—Imiquimod—skin cancer	0.000498	0.00136	CcSEcCtD
Letrozole—Eye disorder—Temozolomide—skin cancer	0.000497	0.00135	CcSEcCtD
Letrozole—Malaise—Bleomycin—skin cancer	0.000495	0.00135	CcSEcCtD
Letrozole—Cardiac disorder—Temozolomide—skin cancer	0.000494	0.00134	CcSEcCtD
Letrozole—Flushing—Temozolomide—skin cancer	0.000494	0.00134	CcSEcCtD
Letrozole—Haemoglobin—Fluorouracil—skin cancer	0.000492	0.00134	CcSEcCtD
Letrozole—Leukopenia—Bleomycin—skin cancer	0.000491	0.00134	CcSEcCtD
Letrozole—Haemorrhage—Fluorouracil—skin cancer	0.00049	0.00133	CcSEcCtD
Letrozole—Dizziness—Vemurafenib—skin cancer	0.000489	0.00133	CcSEcCtD
Letrozole—Hypoaesthesia—Fluorouracil—skin cancer	0.000488	0.00133	CcSEcCtD
Letrozole—Angiopathy—Temozolomide—skin cancer	0.000482	0.00131	CcSEcCtD
Letrozole—Mediastinal disorder—Temozolomide—skin cancer	0.000479	0.0013	CcSEcCtD
Letrozole—Cough—Bleomycin—skin cancer	0.000479	0.0013	CcSEcCtD
Letrozole—Ill-defined disorder—Dactinomycin—skin cancer	0.000475	0.00129	CcSEcCtD
Letrozole—Vomiting—Vemurafenib—skin cancer	0.00047	0.00128	CcSEcCtD
Letrozole—Alopecia—Temozolomide—skin cancer	0.00047	0.00128	CcSEcCtD
Letrozole—Dry skin—Docetaxel—skin cancer	0.000469	0.00128	CcSEcCtD
Letrozole—Myalgia—Bleomycin—skin cancer	0.000467	0.00127	CcSEcCtD
Letrozole—Chest pain—Bleomycin—skin cancer	0.000467	0.00127	CcSEcCtD
Letrozole—Rash—Vemurafenib—skin cancer	0.000466	0.00127	CcSEcCtD
Letrozole—Mental disorder—Temozolomide—skin cancer	0.000466	0.00127	CcSEcCtD
Letrozole—Dermatitis—Vemurafenib—skin cancer	0.000466	0.00127	CcSEcCtD
Letrozole—Headache—Vemurafenib—skin cancer	0.000463	0.00126	CcSEcCtD
Letrozole—Malnutrition—Temozolomide—skin cancer	0.000463	0.00126	CcSEcCtD
Letrozole—Breast disorder—Docetaxel—skin cancer	0.000462	0.00126	CcSEcCtD
Letrozole—Discomfort—Bleomycin—skin cancer	0.000462	0.00126	CcSEcCtD
Letrozole—Malaise—Dactinomycin—skin cancer	0.000462	0.00126	CcSEcCtD
Letrozole—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00046	0.00125	CcSEcCtD
Letrozole—Leukopenia—Dactinomycin—skin cancer	0.000458	0.00125	CcSEcCtD
Letrozole—Dysgeusia—Temozolomide—skin cancer	0.000453	0.00123	CcSEcCtD
Letrozole—Asthenia—Imiquimod—skin cancer	0.000452	0.00123	CcSEcCtD
Letrozole—Anaphylactic shock—Bleomycin—skin cancer	0.000448	0.00122	CcSEcCtD
Letrozole—Oedema—Bleomycin—skin cancer	0.000448	0.00122	CcSEcCtD
Letrozole—Back pain—Temozolomide—skin cancer	0.000448	0.00122	CcSEcCtD
Letrozole—Pruritus—Imiquimod—skin cancer	0.000446	0.00121	CcSEcCtD
Letrozole—Infection—Bleomycin—skin cancer	0.000445	0.00121	CcSEcCtD
Letrozole—Nausea—Vemurafenib—skin cancer	0.000439	0.0012	CcSEcCtD
Letrozole—Vision blurred—Temozolomide—skin cancer	0.000436	0.00119	CcSEcCtD
Letrozole—Myalgia—Dactinomycin—skin cancer	0.000436	0.00119	CcSEcCtD
Letrozole—Alopecia—Fluorouracil—skin cancer	0.000433	0.00118	CcSEcCtD
Letrozole—Diarrhoea—Imiquimod—skin cancer	0.000431	0.00117	CcSEcCtD
Letrozole—Discomfort—Dactinomycin—skin cancer	0.000431	0.00117	CcSEcCtD
Letrozole—Angina pectoris—Docetaxel—skin cancer	0.00043	0.00117	CcSEcCtD
Letrozole—Ill-defined disorder—Temozolomide—skin cancer	0.00043	0.00117	CcSEcCtD
Letrozole—Anorexia—Bleomycin—skin cancer	0.000427	0.00116	CcSEcCtD
Letrozole—Angioedema—Temozolomide—skin cancer	0.000423	0.00115	CcSEcCtD
Letrozole—Oedema—Dactinomycin—skin cancer	0.000418	0.00114	CcSEcCtD
Letrozole—Malaise—Temozolomide—skin cancer	0.000417	0.00114	CcSEcCtD
Letrozole—Dizziness—Imiquimod—skin cancer	0.000417	0.00113	CcSEcCtD
Letrozole—Vertigo—Temozolomide—skin cancer	0.000416	0.00113	CcSEcCtD
Letrozole—Infection—Dactinomycin—skin cancer	0.000415	0.00113	CcSEcCtD
Letrozole—Leukopenia—Temozolomide—skin cancer	0.000414	0.00113	CcSEcCtD
Letrozole—Palpitations—Temozolomide—skin cancer	0.000409	0.00111	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000408	0.00111	CcSEcCtD
Letrozole—Cough—Temozolomide—skin cancer	0.000404	0.0011	CcSEcCtD
Letrozole—Paraesthesia—Bleomycin—skin cancer	0.000402	0.00109	CcSEcCtD
Letrozole—Weight increased—Docetaxel—skin cancer	0.000402	0.00109	CcSEcCtD
Letrozole—Vision blurred—Fluorouracil—skin cancer	0.000402	0.00109	CcSEcCtD
Letrozole—Vomiting—Imiquimod—skin cancer	0.000401	0.00109	CcSEcCtD
Letrozole—Weight decreased—Docetaxel—skin cancer	0.0004	0.00109	CcSEcCtD
Letrozole—Hypertension—Temozolomide—skin cancer	0.0004	0.00109	CcSEcCtD
Letrozole—Dyspnoea—Bleomycin—skin cancer	0.000399	0.00109	CcSEcCtD
Letrozole—Anorexia—Dactinomycin—skin cancer	0.000398	0.00108	CcSEcCtD
Letrozole—Rash—Imiquimod—skin cancer	0.000398	0.00108	CcSEcCtD
Letrozole—Dermatitis—Imiquimod—skin cancer	0.000397	0.00108	CcSEcCtD
Letrozole—Headache—Imiquimod—skin cancer	0.000395	0.00107	CcSEcCtD
Letrozole—Arthralgia—Temozolomide—skin cancer	0.000394	0.00107	CcSEcCtD
Letrozole—Myalgia—Temozolomide—skin cancer	0.000394	0.00107	CcSEcCtD
Letrozole—Infestation NOS—Docetaxel—skin cancer	0.000394	0.00107	CcSEcCtD
Letrozole—Infestation—Docetaxel—skin cancer	0.000394	0.00107	CcSEcCtD
Letrozole—Anxiety—Temozolomide—skin cancer	0.000393	0.00107	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000391	0.00107	CcSEcCtD
Letrozole—Discomfort—Temozolomide—skin cancer	0.000389	0.00106	CcSEcCtD
Letrozole—Decreased appetite—Bleomycin—skin cancer	0.000389	0.00106	CcSEcCtD
Letrozole—Acute coronary syndrome—Docetaxel—skin cancer	0.000388	0.00106	CcSEcCtD
Letrozole—Myocardial infarction—Docetaxel—skin cancer	0.000386	0.00105	CcSEcCtD
Letrozole—Dry mouth—Temozolomide—skin cancer	0.000385	0.00105	CcSEcCtD
Letrozole—Stomatitis—Docetaxel—skin cancer	0.000384	0.00105	CcSEcCtD
Letrozole—Pain—Bleomycin—skin cancer	0.000383	0.00104	CcSEcCtD
Letrozole—Leukopenia—Fluorouracil—skin cancer	0.000382	0.00104	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000381	0.00104	CcSEcCtD
Letrozole—Anaphylactic shock—Temozolomide—skin cancer	0.000378	0.00103	CcSEcCtD
Letrozole—Oedema—Temozolomide—skin cancer	0.000378	0.00103	CcSEcCtD
Letrozole—Infection—Temozolomide—skin cancer	0.000375	0.00102	CcSEcCtD
Letrozole—Nausea—Imiquimod—skin cancer	0.000374	0.00102	CcSEcCtD
Letrozole—Hepatobiliary disease—Docetaxel—skin cancer	0.000373	0.00101	CcSEcCtD
Letrozole—Nervous system disorder—Temozolomide—skin cancer	0.000371	0.00101	CcSEcCtD
Letrozole—Feeling abnormal—Bleomycin—skin cancer	0.000369	0.001	CcSEcCtD
Letrozole—Skin disorder—Temozolomide—skin cancer	0.000367	0.000999	CcSEcCtD
Letrozole—Hyperhidrosis—Temozolomide—skin cancer	0.000365	0.000994	CcSEcCtD
Letrozole—Chest pain—Fluorouracil—skin cancer	0.000363	0.000988	CcSEcCtD
Letrozole—Myalgia—Fluorouracil—skin cancer	0.000363	0.000988	CcSEcCtD
Letrozole—Decreased appetite—Dactinomycin—skin cancer	0.000363	0.000988	CcSEcCtD
Letrozole—Fatigue—Dactinomycin—skin cancer	0.00036	0.00098	CcSEcCtD
Letrozole—Anorexia—Temozolomide—skin cancer	0.00036	0.00098	CcSEcCtD
Letrozole—Discomfort—Fluorouracil—skin cancer	0.000359	0.000976	CcSEcCtD
Letrozole—Pain—Dactinomycin—skin cancer	0.000357	0.000972	CcSEcCtD
Letrozole—Urticaria—Bleomycin—skin cancer	0.000356	0.000968	CcSEcCtD
Letrozole—Haemoglobin—Docetaxel—skin cancer	0.000355	0.000967	CcSEcCtD
Letrozole—Body temperature increased—Bleomycin—skin cancer	0.000354	0.000964	CcSEcCtD
Letrozole—Haemorrhage—Docetaxel—skin cancer	0.000354	0.000963	CcSEcCtD
Letrozole—Hepatitis—Docetaxel—skin cancer	0.000354	0.000963	CcSEcCtD
Letrozole—Hypoaesthesia—Docetaxel—skin cancer	0.000352	0.000958	CcSEcCtD
Letrozole—Urinary tract disorder—Docetaxel—skin cancer	0.000349	0.000951	CcSEcCtD
Letrozole—Oedema peripheral—Docetaxel—skin cancer	0.000348	0.000948	CcSEcCtD
Letrozole—Anaphylactic shock—Fluorouracil—skin cancer	0.000348	0.000947	CcSEcCtD
Letrozole—Oedema—Fluorouracil—skin cancer	0.000348	0.000947	CcSEcCtD
Letrozole—Connective tissue disorder—Docetaxel—skin cancer	0.000348	0.000946	CcSEcCtD
Letrozole—Urethral disorder—Docetaxel—skin cancer	0.000347	0.000944	CcSEcCtD
Letrozole—Infection—Fluorouracil—skin cancer	0.000346	0.000941	CcSEcCtD
Letrozole—Feeling abnormal—Dactinomycin—skin cancer	0.000344	0.000937	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000344	0.000937	CcSEcCtD
Letrozole—Insomnia—Temozolomide—skin cancer	0.000342	0.00093	CcSEcCtD
Letrozole—Gastrointestinal pain—Dactinomycin—skin cancer	0.000342	0.00093	CcSEcCtD
Letrozole—Nervous system disorder—Fluorouracil—skin cancer	0.000341	0.000929	CcSEcCtD
Letrozole—Tachycardia—Fluorouracil—skin cancer	0.00034	0.000925	CcSEcCtD
Letrozole—Paraesthesia—Temozolomide—skin cancer	0.000339	0.000923	CcSEcCtD
Letrozole—Dyspnoea—Temozolomide—skin cancer	0.000337	0.000917	CcSEcCtD
Letrozole—Somnolence—Temozolomide—skin cancer	0.000336	0.000914	CcSEcCtD
Letrozole—Erythema multiforme—Docetaxel—skin cancer	0.000334	0.00091	CcSEcCtD
Letrozole—Dyspepsia—Temozolomide—skin cancer	0.000333	0.000905	CcSEcCtD
Letrozole—Anorexia—Fluorouracil—skin cancer	0.000332	0.000903	CcSEcCtD
Letrozole—Eye disorder—Docetaxel—skin cancer	0.000331	0.0009	CcSEcCtD
Letrozole—Body temperature increased—Dactinomycin—skin cancer	0.00033	0.000899	CcSEcCtD
Letrozole—Abdominal pain—Dactinomycin—skin cancer	0.00033	0.000899	CcSEcCtD
Letrozole—Decreased appetite—Temozolomide—skin cancer	0.000328	0.000894	CcSEcCtD
Letrozole—Cardiac disorder—Docetaxel—skin cancer	0.000328	0.000893	CcSEcCtD
Letrozole—Flushing—Docetaxel—skin cancer	0.000328	0.000893	CcSEcCtD
Letrozole—Gastrointestinal disorder—Temozolomide—skin cancer	0.000326	0.000888	CcSEcCtD
Letrozole—Fatigue—Temozolomide—skin cancer	0.000326	0.000887	CcSEcCtD
Letrozole—Pain—Temozolomide—skin cancer	0.000323	0.000879	CcSEcCtD
Letrozole—Constipation—Temozolomide—skin cancer	0.000323	0.000879	CcSEcCtD
Letrozole—Asthenia—Bleomycin—skin cancer	0.000321	0.000875	CcSEcCtD
Letrozole—Angiopathy—Docetaxel—skin cancer	0.000321	0.000873	CcSEcCtD
Letrozole—Mediastinal disorder—Docetaxel—skin cancer	0.000319	0.000867	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000317	0.000863	CcSEcCtD
Letrozole—Pruritus—Bleomycin—skin cancer	0.000317	0.000862	CcSEcCtD
Letrozole—Insomnia—Fluorouracil—skin cancer	0.000315	0.000857	CcSEcCtD
Letrozole—Paraesthesia—Fluorouracil—skin cancer	0.000313	0.000851	CcSEcCtD
Letrozole—Alopecia—Docetaxel—skin cancer	0.000313	0.000851	CcSEcCtD
Letrozole—Feeling abnormal—Temozolomide—skin cancer	0.000311	0.000847	CcSEcCtD
Letrozole—Dyspnoea—Fluorouracil—skin cancer	0.00031	0.000845	CcSEcCtD
Letrozole—Mental disorder—Docetaxel—skin cancer	0.00031	0.000843	CcSEcCtD
Letrozole—Somnolence—Fluorouracil—skin cancer	0.000309	0.000842	CcSEcCtD
Letrozole—Gastrointestinal pain—Temozolomide—skin cancer	0.000309	0.000841	CcSEcCtD
Letrozole—Malnutrition—Docetaxel—skin cancer	0.000308	0.000838	CcSEcCtD
Letrozole—Dyspepsia—Fluorouracil—skin cancer	0.000306	0.000834	CcSEcCtD
Letrozole—Decreased appetite—Fluorouracil—skin cancer	0.000303	0.000824	CcSEcCtD
Letrozole—Dysgeusia—Docetaxel—skin cancer	0.000301	0.000821	CcSEcCtD
Letrozole—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000301	0.000818	CcSEcCtD
Letrozole—Urticaria—Temozolomide—skin cancer	0.0003	0.000817	CcSEcCtD
Letrozole—Asthenia—Dactinomycin—skin cancer	0.0003	0.000816	CcSEcCtD
Letrozole—Abdominal pain—Temozolomide—skin cancer	0.000299	0.000813	CcSEcCtD
Letrozole—Body temperature increased—Temozolomide—skin cancer	0.000299	0.000813	CcSEcCtD
Letrozole—Back pain—Docetaxel—skin cancer	0.000298	0.00081	CcSEcCtD
Letrozole—Pain—Fluorouracil—skin cancer	0.000298	0.00081	CcSEcCtD
Letrozole—Feeling abnormal—Fluorouracil—skin cancer	0.000287	0.000781	CcSEcCtD
Letrozole—Diarrhoea—Dactinomycin—skin cancer	0.000286	0.000778	CcSEcCtD
Letrozole—Vomiting—Bleomycin—skin cancer	0.000285	0.000775	CcSEcCtD
Letrozole—Rash—Bleomycin—skin cancer	0.000282	0.000769	CcSEcCtD
Letrozole—Dermatitis—Bleomycin—skin cancer	0.000282	0.000768	CcSEcCtD
Letrozole—Urticaria—Fluorouracil—skin cancer	0.000277	0.000753	CcSEcCtD
Letrozole—Leukopenia—Docetaxel—skin cancer	0.000276	0.00075	CcSEcCtD
Letrozole—Body temperature increased—Fluorouracil—skin cancer	0.000275	0.000749	CcSEcCtD
Letrozole—Palpitations—Docetaxel—skin cancer	0.000272	0.00074	CcSEcCtD
Letrozole—Asthenia—Temozolomide—skin cancer	0.000271	0.000738	CcSEcCtD
Letrozole—Cough—Docetaxel—skin cancer	0.000269	0.000731	CcSEcCtD
Letrozole—Pruritus—Temozolomide—skin cancer	0.000267	0.000728	CcSEcCtD
Letrozole—Nausea—Bleomycin—skin cancer	0.000266	0.000724	CcSEcCtD
Letrozole—Hypertension—Docetaxel—skin cancer	0.000266	0.000723	CcSEcCtD
Letrozole—Vomiting—Dactinomycin—skin cancer	0.000266	0.000723	CcSEcCtD
Letrozole—Rash—Dactinomycin—skin cancer	0.000263	0.000717	CcSEcCtD
Letrozole—Arthralgia—Docetaxel—skin cancer	0.000262	0.000713	CcSEcCtD
Letrozole—Chest pain—Docetaxel—skin cancer	0.000262	0.000713	CcSEcCtD
Letrozole—Myalgia—Docetaxel—skin cancer	0.000262	0.000713	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00026	0.000708	CcSEcCtD
Letrozole—Diarrhoea—Temozolomide—skin cancer	0.000259	0.000704	CcSEcCtD
Letrozole—Dry mouth—Docetaxel—skin cancer	0.000256	0.000698	CcSEcCtD
Letrozole—Oedema—Docetaxel—skin cancer	0.000251	0.000684	CcSEcCtD
Letrozole—Anaphylactic shock—Docetaxel—skin cancer	0.000251	0.000684	CcSEcCtD
Letrozole—Dizziness—Temozolomide—skin cancer	0.00025	0.00068	CcSEcCtD
Letrozole—Infection—Docetaxel—skin cancer	0.00025	0.000679	CcSEcCtD
Letrozole—Nausea—Dactinomycin—skin cancer	0.000248	0.000675	CcSEcCtD
Letrozole—Nervous system disorder—Docetaxel—skin cancer	0.000246	0.000671	CcSEcCtD
Letrozole—Pruritus—Fluorouracil—skin cancer	0.000246	0.00067	CcSEcCtD
Letrozole—Tachycardia—Docetaxel—skin cancer	0.000245	0.000667	CcSEcCtD
Letrozole—Skin disorder—Docetaxel—skin cancer	0.000244	0.000664	CcSEcCtD
Letrozole—Vomiting—Temozolomide—skin cancer	0.00024	0.000654	CcSEcCtD
Letrozole—Anorexia—Docetaxel—skin cancer	0.00024	0.000652	CcSEcCtD
Letrozole—Rash—Temozolomide—skin cancer	0.000238	0.000648	CcSEcCtD
Letrozole—Diarrhoea—Fluorouracil—skin cancer	0.000238	0.000648	CcSEcCtD
Letrozole—Dermatitis—Temozolomide—skin cancer	0.000238	0.000648	CcSEcCtD
Letrozole—Headache—Temozolomide—skin cancer	0.000237	0.000644	CcSEcCtD
Letrozole—Dizziness—Fluorouracil—skin cancer	0.00023	0.000627	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000229	0.000623	CcSEcCtD
Letrozole—Insomnia—Docetaxel—skin cancer	0.000227	0.000619	CcSEcCtD
Letrozole—Paraesthesia—Docetaxel—skin cancer	0.000226	0.000614	CcSEcCtD
Letrozole—Nausea—Temozolomide—skin cancer	0.000224	0.000611	CcSEcCtD
Letrozole—Dyspnoea—Docetaxel—skin cancer	0.000224	0.00061	CcSEcCtD
Letrozole—Somnolence—Docetaxel—skin cancer	0.000223	0.000608	CcSEcCtD
Letrozole—Vomiting—Fluorouracil—skin cancer	0.000221	0.000602	CcSEcCtD
Letrozole—Dyspepsia—Docetaxel—skin cancer	0.000221	0.000602	CcSEcCtD
Letrozole—Rash—Fluorouracil—skin cancer	0.000219	0.000597	CcSEcCtD
Letrozole—Dermatitis—Fluorouracil—skin cancer	0.000219	0.000597	CcSEcCtD
Letrozole—Decreased appetite—Docetaxel—skin cancer	0.000218	0.000594	CcSEcCtD
Letrozole—Headache—Fluorouracil—skin cancer	0.000218	0.000594	CcSEcCtD
Letrozole—Gastrointestinal disorder—Docetaxel—skin cancer	0.000217	0.00059	CcSEcCtD
Letrozole—Fatigue—Docetaxel—skin cancer	0.000217	0.00059	CcSEcCtD
Letrozole—Constipation—Docetaxel—skin cancer	0.000215	0.000585	CcSEcCtD
Letrozole—Pain—Docetaxel—skin cancer	0.000215	0.000585	CcSEcCtD
Letrozole—Feeling abnormal—Docetaxel—skin cancer	0.000207	0.000564	CcSEcCtD
Letrozole—Nausea—Fluorouracil—skin cancer	0.000207	0.000563	CcSEcCtD
Letrozole—Gastrointestinal pain—Docetaxel—skin cancer	0.000205	0.000559	CcSEcCtD
Letrozole—Abdominal pain—Docetaxel—skin cancer	0.000199	0.000541	CcSEcCtD
Letrozole—Body temperature increased—Docetaxel—skin cancer	0.000199	0.000541	CcSEcCtD
Letrozole—Asthenia—Docetaxel—skin cancer	0.00018	0.000491	CcSEcCtD
Letrozole—Pruritus—Docetaxel—skin cancer	0.000178	0.000484	CcSEcCtD
Letrozole—Diarrhoea—Docetaxel—skin cancer	0.000172	0.000468	CcSEcCtD
Letrozole—Dizziness—Docetaxel—skin cancer	0.000166	0.000452	CcSEcCtD
Letrozole—Vomiting—Docetaxel—skin cancer	0.00016	0.000435	CcSEcCtD
Letrozole—Rash—Docetaxel—skin cancer	0.000158	0.000431	CcSEcCtD
Letrozole—Dermatitis—Docetaxel—skin cancer	0.000158	0.000431	CcSEcCtD
Letrozole—Headache—Docetaxel—skin cancer	0.000157	0.000428	CcSEcCtD
Letrozole—Nausea—Docetaxel—skin cancer	0.000149	0.000406	CcSEcCtD
